Granulocyte-macrophage colony-stimulating factor (GM-CSF) and cytokine levels (IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and TNF-) were determined using the Bio-Rad Bio-Plex Luminex 200 multiplex assay system
This could increase demand within Medicare Advantage plans operating in the state and place new emphasis on care coordination, prior authorization workflows, and provider education
Laboratory studies suggest the peptide can shift gene-expression patterns toward a profile associated with younger tissue and may support the activity of cells involved in repair
After submitting your inquiry, a member of our support staff will contact you promptly with product details, pricing options, and next steps toward procurement
Human evidence - Phase 2 type 2 diabetes (Rosenstock et al., Lancet 2023) Adults with type 2 diabetes, 36 weeks